newsfilter
← Latest News
GlobeNewswire·

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital

BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral